American Hemp Ventures, Inc.
American Hemp Ventures, Inc. (AMHV) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
amhv · pe ratio · data through Jun 8, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
American Hemp Ventures, Inc.You AMHV | $16M | N/A | — | — |
 Avecho Biotechnology Limited AVEFF | $11M | N/A | — | -$0.00 |
 Ceapro Inc. CRPOF | $13M | N/A | — | -$0.06 |
 Eiger BioPharmaceuticals, Inc. EIGRQ | $13M | N/A | — | -$50.78 |
 Noxopharm Limited NOXOF | $15M | N/A | — | -$0.01 |
 Organicell Regenerative Medicine, Inc. OCEL | $20M | N/A | — | -$0.86 |
 OptiBiotix Health Plc OPBXF | $20M | 6.55x | — | $0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for American Hemp Ventures, Inc. (AMHV) measures how much investors pay for each dollar of the company's trailing earnings. AMHV's current PE ratio of N/A is calculated by dividing its stock price of $0.98 by its TTM earnings per share of —.
Frequently asked questions
AMHV pe ratio · 6 questionsAMHV's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.98 and TTM EPS of —. Data sourced from Financial Modeling Prep via AMHV's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · American Hemp Ventures, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08